Le Moigne, R, et. al. Treatment of castrated resistant prostate cancer, with EPI-7386, a second generation N-terminal domain androgen receptor inhibitor. The 26th Annual Scientific Retreat | Prostate Cancer Foundation.

Read More > Prostate Cancer Foundation Annual Retreat Poster